Physician profile
Joan M Dutton
NPI 1336494319
$1,673.29
in general payments reported to CMS, 2019-2025
18 companies · $973 in 2025
The $973 reported for 2025 was more than what 87% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $700 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,539 · Travel and Lodging: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,539.27 |
| Travel and Lodging | $134.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $690.47 | 2024-2025 | Cardiomems, Jot Dx |
| Abiomed | $132.75 | 2025 | |
| Novartis Pharmaceuticals Corporation | $125.61 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $117.14 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.21 | 2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.97 | 2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $73.83 | 2024-2025 | Farxiga |
| Novo Nordisk INC | $64.30 | 2025 | Wegovy |
| Alnylam Pharmaceuticals INC. | $56.41 | 2025 | Amvuttra |
| Scpharmaceuticals INC. | $54.32 | 2024-2025 | |
| Pfizer INC. | $36.81 | 2025 | |
| Organogenesis INC. | $23.31 | 2025 | Puraply Wound Matrix |
| Abbvie INC. | $21.89 | 2024 | |
| Atricure, INC. | $19.84 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $19.17 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $19.06 | 2025 | Uptravi, Opsynvi |
| E.R. Squibb & Sons, L.L.C. | $16.11 | 2025 | Camzyos |
| Janssen Pharmaceuticals, INC | $15.09 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Dutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.